Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.

Jørgensen KJ, Gøtzsche PC, Kalager M, Zahl PH.

Ann Intern Med. 2017 Mar 7;166(5):313-323. doi: 10.7326/M16-0270. Epub 2017 Jan 10.

PMID:
28114661
2.

Breast Cancer Screening: Benefit or Harm?

Jørgensen KJ, Gøtzsche PC.

JAMA. 2016 Apr 5;315(13):1402. doi: 10.1001/jama.2015.19126. No abstract available.

PMID:
27046370
3.

Breast cancer: Updated screening guidelines - much ado about small improvements.

Jørgensen KJ, Gøtzsche PC.

Nat Rev Clin Oncol. 2016 Mar;13(3):139-40. doi: 10.1038/nrclinonc.2015.232. Epub 2015 Dec 31. No abstract available.

PMID:
26718110
4.

Mammography screening is harmful and should be abandoned.

Gøtzsche PC.

J R Soc Med. 2015 Sep;108(9):341-5. doi: 10.1177/0141076815602452. No abstract available.

PMID:
26359135
5.

Lead-time models produce far too low estimates of overdiagnosis with mammographic screening.

Gøtzsche PC, Jørgensen KJ, Zahl PH.

J Am Coll Radiol. 2014 Nov;11(11):1098. doi: 10.1016/j.jacr.2014.08.008. Epub 2014 Oct 7. No abstract available.

PMID:
25301416
6.

Time to halt an out of control trial with ineffective oversight.

Bewley S, Rose L, Gøtzsche P, Blennerhassett M, Colquhoun D, Pryke M, Tindall G, Braillon A, Richmond C, Illman J, May J.

BMJ. 2014 Sep 16;349:g5601. doi: 10.1136/bmj.g5601. No abstract available.

PMID:
25232068
7.

Influence of mammography screening on use of mastectomies in Denmark.

Jørgensen KJ, Zahl PH, Gøtzsche PC.

Acta Oncol. 2015 Jan;54(1):133-4. doi: 10.3109/0284186X.2014.920958. Epub 2014 Jun 1. No abstract available.

PMID:
24881500
8.

Lead-time models should not be used to estimate overdiagnosis in cancer screening.

Zahl PH, Jørgensen KJ, Gøtzsche PC.

J Gen Intern Med. 2014 Sep;29(9):1283-6. doi: 10.1007/s11606-014-2812-2. Epub 2014 Mar 4. Review.

9.

Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.

Zahl PH, Jørgensen KJ, Gøtzsche PC.

Br J Cancer. 2013 Oct 1;109(7):2014-9. doi: 10.1038/bjc.2013.427. Epub 2013 Aug 20.

10.

Screening for breast cancer with mammography.

Gøtzsche PC, Jørgensen KJ.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877. doi: 10.1002/14651858.CD001877.pub5. Review.

11.

[Misleading by the Danish Cancer Society about mammography screening].

Gøtzsche PC.

Ugeskr Laeger. 2013 Apr 8;175(15):1056. Danish. No abstract available.

PMID:
23734386
12.

The benefits and harms of breast cancer screening.

Gøtzsche PC, Jørgensen KJ.

Lancet. 2013 Mar 9;381(9869):799. doi: 10.1016/S0140-6736(13)60618-2. Epub 2013 Mar 8. No abstract available.

PMID:
23668503
13.

Citations of scientific results and conflicts of interest: the case of mammography screening.

Rasmussen K, Jørgensen KJ, Gøtzsche PC.

Evid Based Med. 2013 Jun;18(3):83-9. doi: 10.1136/eb-2012-101216. Epub 2013 May 1.

14.

Effect of screening mammography on breast cancer incidence.

Jørgensen KJ, Gøtzsche PC.

N Engl J Med. 2013 Feb 14;368(7):677-8. doi: 10.1056/NEJMc1215494#SA2. No abstract available.

PMID:
23406036
15.

Thirteen years of breast screening had no measurable effect on breast cancer mortality in Norway.

Jørgensen KJ, Brodersen J, Gøtzsche PC.

Int J Cancer. 2013 Apr 1;132(7):1725-6. doi: 10.1002/ijc.27808. Epub 2012 Oct 17. No abstract available.

16.

Mammography screening: truth, lies, and controversy.

Gøtzsche PC.

Lancet. 2012 Jul 21;380(9838):218. doi: 10.1016/S0140-6736(12)61216-1. No abstract available.

PMID:
22817975
17.

[Mortality in breast cancer is decreasing--but not because of screening. Time to abolish the mammography screening].

Jørgensen KJ, Gøtzsche PC.

Lakartidningen. 2012 Mar 28-Apr 3;109(13):690-2. Review. Swedish. No abstract available.

PMID:
22530466
18.

The Two-County breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening.

Jørgensen KJ, Keen JD, Zahl PH, Gøtzsche PC.

Radiology. 2012 Feb;262(2):729-30; author reply 730-1. doi: 10.1148/radiol.11111756. No abstract available.

PMID:
22282190
19.

Effect of population-based screening on breast cancer mortality.

Gøtzsche PC, Jørgensen KJ.

Lancet. 2012 Apr 7;379(9823):1297; author reply 1298. doi: 10.1016/S0140-6736(12)60039-7. Epub 2012 Jan 11. No abstract available.

PMID:
22240405
20.

The proposed review will not be independent without NICE.

Jørgensen KJ, Gøtzsche PC.

BMJ. 2011 Nov 22;343:d7533. doi: 10.1136/bmj.d7533. No abstract available.

PMID:
22108266

Supplemental Content

Loading ...
Support Center